Summary of Dr. Liu Su′s Experience in the Diagnosis and Treatment of Chronic Atrophic Gastritis

Abstract

Abstract: Chronic atrophic gastritis is a common disease of digestive system. If it is not controlled in time, it can further evolve into intestinal metaplasia, dysplasia, and gastric cancer, posing a huge threat to human health. Dr. Liu Su, the chief physician, believes that the main pathogenesis of chronic atrophic gastritis is “liver depression and spleen deficiency, accompanied by heat, phlegm, and blood stasis”. He advocates the treatment principle of “soothing the liver and strengthening the spleen, clearing heat and phlegm,and resolving blood stasis and detoxification”, with obvious clinical efficacy.

Key words: chronic atrophic gastritis, diagnosis and treatment based on syndrome differentiation, experience summary, soothing the liver and strengthening the spleen

CLC Number:

R256.3

ZHANG Xian-yao, ZHANG Hua-zhong, LEI Ming-zhi, LIU Su. Summary of Dr. Liu Su′s Experience in the Diagnosis and Treatment of Chronic Atrophic Gastritis[J]. ZHONGHUA YANGSHENG BAOJIAN, 2025, 43(3): 162-166.

References

[1] 李军祥,陈誩,吕宾,等.慢性萎缩性胃炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,26(2):121-131.
[2] 刘岩生,白米楠,胡贺,等.国医大师李佃贵活血化瘀法辨证治疗慢性萎缩性胃炎的经验[J].世界中西医结合杂志,2024,19(2):261-265.
[3] 李宏霖,陈慧婷,林慧光,等.林慧光教授治疗慢性萎缩性胃炎伴肠上皮化生经验[J].山西中医药大学学报,2024,25(2):178-181,185.
[4] 侯桐欣,高宇,郑世行,等.国医大师王晞星分期论治慢性萎缩性胃炎伴肠化生经验探讨[J].世界中西医结合杂志,2023,18(7):1319-1322,1328.
[5] 陈静,徐蕾,曹正民,等.姚乃礼教授从“肝郁脾虚,络阻毒损”论治慢性萎缩性胃炎经验[J].天津中医药大学学报,2022,41(3):295-299.
[6] 郑波,黄玉静,张文涛.郑邦本应用半白六君子汤治疗慢性萎缩性胃炎伴肠上皮化生经验[J].实用中医药杂志,2024,40(2):366-368.
[7] 段永强,王道坤.王道坤教授从“脾胃失调”论治慢性萎缩性胃炎病机要素分析[J].时珍国医国药,2014,25(7):1715-1717.
[8] 张硕,张庆祥.张珍玉从肝论治脾胃病经验探析[J].辽宁中医杂志,2022,49(7):41-44.
[9] 林梅. 慢性萎缩性胃炎伴不同糜烂形态与“湿”“痰”“瘀”的相关性研究[D].福州:福建中医药大学,2020.
[10] 段永强,王君,成映霞.王道坤运用枳实消痞汤辨治老年慢性萎缩性胃炎经验介绍[J].新中医,2016,48(11):153-155.
[11] 李枝锦,吴平财.慢性萎缩性胃炎的微观辨证研究进展[J].中国中西医结合消化杂志,2020,28(1):72-76.
[12] 熊山,丁晓晨.四君子汤化学成分和药理作用研究进展[J].山东医学高等专科学校学报,2017,39(5):371-374.
[13] 王海强,周千瑶,李冰琪,等.柴胡化学成分及药理作用研究进展[J].吉林中医药,2024,44(1):96-100.
[14] 黄烈岩,聂黎行,康帅,等.黄芩化学成分、药理作用和质量控制的研究进展[J].辽宁中医药大学学报,2024,26(4):88-96.
[15] 崔红倩,迟宇昊,申远.白芍的化学成分和药理作用研究进展[J].新乡医学院学报,2024,41(3):291-297.
[16] 魏巍,王冰瑶.莪术及其主要成分的药理作用研究进展[J].药物评价研究,2022,45(10):2154-2160.
[17] 王婉怡,朱志军,李航飞,等.半夏化学成分、药理作用研究进展及其质量标志物预测分析[J].辽宁中医药大学学报,2024,26(3):203-215.
[18] 陈雨彤,叶琳若,崔琦,等.浙贝母化学成分和药理作用的研究进展及其质量标志物预测分析[J].中医药信息,2024,41(6):60-75+81.
[19] 李国旺,吴佳伟,高秀娟,等.蒲公英抗肿瘤研究进展[J].中国中医药现代远程教育,2024,22(1):157-159.
[20] 徐楚楚,苏晓兰,潘雨烟,等.基于网络药理学的白花蛇舌草-半枝莲药对治疗胃癌前病变作用机制研究[J].北京中医药,2021,40(8):901-906.
[21] 蔡秀江,李红,杨海慧,等.四君子汤临床应用研究进展[J].实用中医药杂志,2023,39(11):2286-2288.